Harbour Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Harbour Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$952K	Buy	4,958 +120	+2%	+$20.6K	0.17%	119
2026 Q1	$844K	Buy	4,838 +60	+1%	+$10.3K	0.16%	127
2025 Q4	$807K	Sell	4,778 -725	-13%	-$118K	0.16%	131
2025 Q3	$828K	Sell	5,503 -60	-1%	-$8.19K	0.17%	131
2025 Q2	$721K	Hold	5,563	–	–	0.15%	145
2025 Q1	$689K	Sell	5,563 -165	-3%	-$22.4K	0.17%	132
2024 Q4	$768K	Sell	5,728 -50	-0.9%	-$7.03K	0.17%	122
2024 Q3	$827K	Buy	5,778 +120	+2%	+$17.4K	0.19%	118
2024 Q2	$775K	Hold	5,658	–	–	0.18%	120
2024 Q1	$758K	Hold	5,658	–	–	0.19%	123
2023 Q4	$769K	Hold	5,658	–	–	0.21%	103
2023 Q3	$692K	Hold	5,658	–	–	0.21%	115
2023 Q2	$717K	Hold	5,658	–	–	0.21%	108
2023 Q1	$731K	Hold	5,658	–	–	0.22%	107
2022 Q4	$736K	Sell	5,658 -105	-2%	-$13.6K	0.25%	93
2022 Q3	$680K	Hold	5,763	–	–	0.24%	103
2022 Q2	$678K	Hold	5,763	–	–	0.22%	105
2022 Q1	$751K	Hold	5,763	–	–	0.21%	111
2021 Q4	$880K	Hold	5,763	–	–	0.22%	107
2021 Q3	$932K	Sell	5,763 -30	-0.5%	-$5.05K	0.25%	106
2021 Q2	$948K	Sell	5,793 -4	-0.1%	-$616	0.25%	103
2021 Q1	$873K	Buy	+5,797	New	+$921K	0.26%	98
2020 Q4	–	Sell	-5,879	Closed	-$796K	–	126
2020 Q3	$796K	Hold	5,879	–	–	0.29%	92
2020 Q2	$804K	Hold	5,879	–	–	0.33%	86
2020 Q1	$633K	Hold	5,879	–	–	0.32%	91
2019 Q4	$708K	Sell	5,879 -710	-11%	-$79.2K	0.27%	96
2019 Q3	$656K	Sell	6,589 -375	-5%	-$39.3K	0.28%	100
2019 Q2	$760K	Sell	6,964 -460	-6%	-$48.9K	0.33%	89
2019 Q1	$830K	Sell	7,424 -200	-3%	-$21.9K	0.37%	86
2018 Q4	$735K	Buy	+7,624	New	+$809K	0.37%	92
2018 Q3	–	Sell	-8,454	Closed	-$936K	–	206
2018 Q2	$936K	Sell	8,454 -135	-2%	-$14.4K	0.4%	90
2018 Q1	$917K	Sell	8,589 -225	-3%	-$24.9K	0.39%	90
2017 Q4	$941K	Buy	8,814 +765	+10%	+$81.8K	0.39%	90
2017 Q3	$895K	Hold	8,049	–	–	0.39%	87
2017 Q2	$832K	Sell	8,049 -555	-6%	-$54.7K	0.41%	85
2017 Q1	$841K	Sell	8,604 -225	-3%	-$21.5K	0.38%	87
2016 Q4	$781K	Sell	8,829 -51	-0.6%	-$4.64K	0.56%	69
2016 Q3	$857K	Sell	8,880 -210	-2%	-$20K	0.54%	61
2016 Q2	$780K	Hold	9,090	–	–	0.44%	81
2016 Q1	$790K	Sell	9,090 -195	-2%	-$17.4K	0.45%	76
2015 Q4	$1.05M	Hold	9,285	–	–	0.57%	51
2015 Q3	$939K	Hold	9,285	–	–	0.66%	49
2015 Q2	$1.14M	Hold	9,285	–	–	0.71%	33
2015 Q1	$1.06M	Hold	9,285	–	–	0.74%	32
2014 Q4	$939K	Hold	9,285	–	–	0.67%	39
2014 Q3	$847K	Hold	9,285	–	–	0.7%	47
2014 Q2	$796K	Hold	9,285	–	–	0.63%	50
2014 Q1	$732K	Buy	9,285 +720	+8%	+$60K	0.69%	48
2013 Q4	$648K	Hold	8,565	–	–	0.57%	62
2013 Q3	$598K	Buy	8,565 +300	+4%	+$19.7K	0.65%	52
2013 Q2	$479K	Buy	+8,265	New	+$478K	0.6%	61

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Harbour Capital Advisors's IBB Position: Q2 2026 in Review

Harbour Capital Advisors increased its iShares Biotechnology ETF (IBB) stake by 2.5% in Q2 2026, buying an estimated $20.6K and bringing the position to 4,958 shares worth $952K. The position accounts for 0.17% of the portfolio, ranked #119.

Harbour Capital Advisors first reported a position in IBB in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.14M in Q2 2015. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Harbour Capital Advisors held 4,958 shares of iShares Biotechnology ETF worth $952K as of Q2 2026.
Harbour Capital Advisors bought 120 iShares Biotechnology ETF shares in Q2 2026, an estimated $20.6K.
iShares Biotechnology ETF made up 0.17% of Harbour Capital Advisors's portfolio in Q2 2026, its #119 holding.
Harbour Capital Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 51 quarters since.
Harbour Capital Advisors's iShares Biotechnology ETF position peaked at $1.14M in Q2 2015.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.